Key result
CRT enables ~82% of dependent NYHA-IV HF patients to wean from IV or invasive support.
Why the study?
The effectiveness of CRT in far-advanced HF patients with NYHA class-IV status dependent on intravenous drugs and/or invasive supportive treatments was unclear.
Does cardiac resynchronization therapy improve clinical outcomes and allow weaning from intravenous drugs or invasive supportive treatments in NYHA class-IV far-advanced heart failure patients?
Population
17 far-advanced HF patients with NYHA class-IV status dependent on IVDs and/or ISTs
Comparison
CRT implantation outcomes in IVD/IST-dependent patients
Design
Cohort study
Follow-up
35 ± 15 months
Authors
Loading...
May support CRT for weaning in select dependent NYHA-IV HF; hypothesis-generating and requires randomized confirmation.
Cohort (n=17)
Does cardiac resynchronization therapy improve clinical outcomes and allow weaning from intravenous drugs or invasive supportive treatments in NYHA class-IV far-advanced heart failure patients?
CRT implantation may be a feasible and beneficial treatment option for select NYHA class-IV far-advanced heart failure patients dependent on intravenous drugs or invasive supportive treatments, facilitating weaning and improving survival.
Lee et al. (2020) conducted a cohort in Far-advanced heart failure (NYHA class-IV) dependent on intravenous drugs or invasive supportive treatments (n=17). Cardiac resynchronization therapy (CRT) was evaluated on Successful weaning from intravenous drugs or invasive supportive treatments. Cardiac resynchronization therapy enabled successful weaning from intravenous drugs or invasive supportive treatments in 82% of dependent NYHA class-IV heart failure patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: